A number of other equities research analysts also recently weighed in on the company. JPMorgan Chase & Co. set a €87.70 ($108.27) price target on Gerresheimer and gave the company a buy rating in a research report on Thursday, January 4th. Berenberg Bank set a €75.00 ($92.59) price objective on Gerresheimer and gave the stock a buy rating in a report on Friday, December 8th. Deutsche Bank set a €64.00 ($79.01) price objective on Gerresheimer and gave the stock a neutral rating in a report on Friday, December 1st. Kepler Capital Markets set a €65.00 ($80.25) price objective on Gerresheimer and gave the stock a sell rating in a report on Friday, November 3rd. Finally, Commerzbank set a €77.00 ($95.06) price objective on Gerresheimer and gave the stock a buy rating in a report on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. Gerresheimer presently has an average rating of Hold and a consensus target price of €71.61 ($88.41).
Shares of Gerresheimer (ETR GXI) traded down €1.35 ($1.67) during mid-day trading on Thursday, hitting €64.40 ($79.51). The company had a trading volume of 139,645 shares, compared to its average volume of 116,507. Gerresheimer has a one year low of €59.97 ($74.04) and a one year high of €78.25 ($96.60). The stock has a market capitalization of $2,020.00 and a P/E ratio of 45.67.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.